XML 87 R52.htm IDEA: XBRL DOCUMENT v3.25.0.1
INCENTIVE COMPENSATION (Tables)
12 Months Ended
Dec. 29, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Compensation Cost and Income Tax Benefit
Compensation costs and the income tax benefit recognized for our stock-based compensation arrangements are included below:
202420232022
(In thousands)
Equity-based awards compensation cost
Cost of sales$2,439 $629 $959 
Selling, general and administrative expense12,975 6,958 5,904 
Total cost15,414 7,587 6,863 
Income tax benefit3,730 1,836 1,671 
Net cost$11,684 $5,751 $5,192 
Liability-based awards compensation cost
Selling, general and administrative expense(a)
$(1,953)$2,491 $1,773 
Income tax benefit (expense)(473)603 432 
Net cost(a)
$(1,480)$1,888 $1,341 
(a)During 2024, the liability-based awards in our Europe and Mexico segments for the 2023 performance year were determined to have not met the performance threshold for payout therefore the Company reversed the prior and current year recognized compensation costs related to these awards.
Schedule of RSU Activity
The Company’s RSU activity is included below:
202420232022
Number
Weighted Average Milestone Date Fair Value(a)
Number
Weighted Average Milestone Date Fair Value(a)
Number
Weighted Average Milestone Date Fair Value(a)
(In thousands, except weighted average fair values)
Equity-based RSUs
Outstanding at beginning of year911 $22.40 993 $22.00 554 $20.40 
Granted979 26.80 324 23.67 405 23.88 
Vested(187)21.76 (378)22.25 (266)23.25 
Awards reinstated (forfeited)(131)21.70 (28)24.99 300 23.52 
Outstanding at end of year1,572 $25.27 911 $22.40 993$22.00 
202420232022
Number
Weighted Average Milestone Date Fair Value(a)
Number
Weighted Average Milestone Date Fair Value(a)
Number
Weighted Average Milestone Date Fair Value(a)
(In thousands, except weighted average fair values)
Liability-based RSUs
Outstanding at beginning of year242 $27.66 377 $23.80 574 $27.55 
Granted— — 158 24.21 269 22.09 
Vested— — (196)25.27 (139)27.55 
Forfeited(218)34.32 (97)22.81 (327)24.71 
Outstanding at end of year24 $45.92 242 $27.66 377 $23.80 
(a)The milestone date fair value is either the closing price of the Company’s common stock on the grant date for equity-based awards or the closing price of a share of the Company’s common stock on the respective milestone date for cash-based liability-based awards (i.e., grant date, vesting date, forfeiture date or financial reporting date).